Table 1 Baseline characteristics of study participants (n = 10 per group)

Age (years)

54.7 ± 8.4

58.4 ± 7.6

Weight (kg)^a

85.5 ± 8.3

98.3 ± 19

BMI (kg/m²)^a

31.5 ± 3.3

36.9 ± 7.7

Body fat (%)

49.4 ± 4.8

50.6 ± 3.7

Bone mineral density (g/cm²)

1.18 ± 0.11

1.26 ± 0.09

Fitness level (METs)

4.89 ± 1.48

4.80 ± 0.97

Glucose (mg/dL)^b

80.7 ± 9.8

96.5 ± 21.8

Insulin (mU/L)^b

9.0 ± 4.1

19.4 ± 20.7

25(OH)vitamin D (ng/mL)

35.0 ± 9.4

33.1 ± 12

 Yes

4

3

 No

6

7

 Stage I

2

4

 Stage II

7

4

 Stage III

1

2

 Yes

10

9

 No

0

1

 Aromatase inhibitors

4

5

 Selective estrogen receptor modulators

4

3

 None

2

2

 Yes

5

6

 No

3

0

 Lumpectomy

2

4

 White

10

10

 Other

0

0